Flunixin meglumine
USP/1274607 - United States Pharmacopeia (USP) Reference Standard
Synonym: 2-
CAS Number: 42461-84-7
Empirical Formula (Hill Notation): C14H11F3N2O2·C7H17NO5
Molecular Weight: 491.46
MDL Number: MFCD01725419
Linear Formula: C14H11F3N2O2·C7H17NO5
Product Type: Chemical
API family | flunixin |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C14H11F3N2O2.C7H17NO5/ |
InChI key | MGCCHNLNRBULBU-WZTVWXICSA |
manufacturer/tradename | USP |
SMILES string | CNC[C@H](O)[C@@H](O)[C@H] |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | Flunixin meglumine (IC50 = 1 nM) can be used as a drug for animals for the management of intestinal ischaemia, colic, and endotoxemia in horses. |
Biochem/physiol Actions: | COX1, COX2 and PLA2 inhibitor non-narcotic analgesic, anti-pyretic, anti-inflammatory. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia ![]() ![]() |
Other Notes: | Sales restrictions may apply. |
Symbol | ![]() |
Signal word | Warning |
Hazard statements | H315 - H319 - H335 |
Precautionary statements | P305 + P351 + P338 |
RIDADR | UN 2811 6.1 / PGI |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
UNSPSC | 41116107 |